Skip to content
ClinCalc Pro
Menu
Potent corticosteroid + imidazole antifungal

Betamethasone with clotrimazole

Brand names: Lotriderm

A topical fixed-combination cream pairing the potent corticosteroid betamethasone with the imidazole antifungal clotrimazole, used for inflamed fungal skin infections such as tinea or candidal intertrigo where inflammation is prominent.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Betamethasone suppresses local inflammation, vasodilatation and immune activity, while clotrimazole inhibits fungal ergosterol synthesis to disrupt the cell membrane of dermatophytes and yeasts.

Prescribing in practice

  • The corticosteroid component can mask and worsen an untreated infection, so use should be short-term and limited to genuinely inflamed fungal disease rather than as a routine antifungal.
  • Avoid prolonged application to the face, flexures or large areas, and avoid occlusion, which increases corticosteroid potency and absorption.
  • Not appropriate as monotherapy for established dermatophyte infection if inflammation is minimal — a plain antifungal is preferred.

Monitoring

Review the response after a short course and reassess the diagnosis if the rash fails to clear or recurs, considering skin scrapings for mycology.

Counselling the patient

  • Apply a thin layer to the affected area as directed and do not cover with airtight dressings unless told to.
  • Stop and seek advice if the area becomes more sore, weepy or fails to improve.

Evidence & guidelines

Use is guided by SPC recommendations and standard dermatology practice for inflamed superficial fungal infection; consult current prescribing references.

Reference: NICE CKS Tinea; BAD; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.